Follow
Gert van Zyl
Gert van Zyl
Division of Medical Virology, Stellenbosch University and NHLS Tygerberg
Verified email at sun.ac.za
Title
Cited by
Cited by
Year
Detection of a SARS-CoV-2 variant of concern in South Africa
H Tegally, E Wilkinson, M Giovanetti, A Iranzadeh, V Fonseca, ...
Nature 592 (7854), 438-443, 2021
14342021
Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa
H Tegally, E Wilkinson, M Giovanetti, A Iranzadeh, V Fonseca, ...
medrxiv, 2020.12. 21.20248640, 2020
11922020
Sixteen novel lineages of SARS-CoV-2 in South Africa
H Tegally, E Wilkinson, RJ Lessells, J Giandhari, S Pillay, N Msomi, ...
Nature medicine 27 (3), 440-446, 2021
3612021
HIV treatment adherence, drug resistance, virologic failure: evolving concepts
JB Nachega, VC Marconi, GU Van Zyl, EM Gardner, W Preiser, SY Hong, ...
Infectious disorders drug targets 11 (2), 167, 2011
3022011
Adult antiretroviral therapy guidelines 2017
G Meintjes, MA Moorhouse, S Carmona, N Davies, S Dlamini, ...
Southern African journal of HIV medicine 18 (1), 1-24, 2017
2352017
Kosakovsky Pond SL, Weaver S, Martin D, Lessells RJ, Bhiman JN, Williamson C, de Oliveira T. Detection of a SARS-CoV-2 variant of concern in South Africa
H Tegally, E Wilkinson, M Giovanetti, A Iranzadeh, V Fonseca, ...
Nature 592 (7854), 438-443, 2021
2142021
A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa
E Wilkinson, M Giovanetti, H Tegally, JE San, R Lessells, D Cuadros, ...
Science 374 (6566), 423-431, 2021
1822021
Emergence of HIV drug resistance during first-and second-line antiretroviral therapy in resource-limited settings
MC Hosseinipour, RK Gupta, G Van Zyl, JJ Eron, JB Nachega
The Journal of infectious diseases 207 (suppl_2), S49-S56, 2013
1682013
Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein
H Tegally, E Wilkinson, M Giovanetti, A Iranzadeh, V Fonseca, ...
Nature 592 (7854), 438-443, 2021
1452021
Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting
GU Van Zyl, TE Van Mens, H McIlleron, M Zeier, JB Nachega, E Decloedt, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 56 (4), 333-339, 2011
1322011
Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy
ET Marinda, J Hargrove, W Preiser, H Slabbert, G Van Zyl, J Levin, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 53 (4), 496-499, 2010
1012010
HIV-1 drug resistance mutations: potential applications for point-of-care genotypic resistance testing
SY Rhee, MR Jordan, E Raizes, A Chua, N Parkin, R Kantor, GU Van Zyl, ...
PloS one 10 (12), e0145772, 2015
1002015
No evidence of HIV replication in children on antiretroviral therapy
GU Van Zyl, MG Katusiime, A Wiegand, WR McManus, MJ Bale, ...
The Journal of clinical investigation 127 (10), 3827-3834, 2017
832017
Trends in genotypic HIV-1 antiretroviral resistance between 2006 and 2012 in South African patients receiving first-and second-line antiretroviral treatment regimens
GU Van Zyl, TF Liu, M Claassen, S Engelbrecht, T De Oliveira, W Preiser, ...
PloS one 8 (6), e67188, 2013
832013
The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance
H Tegally, JE San, M Cotten, M Moir, B Tegomoh, G Mboowa, DP Martin, ...
Science 378 (6615), eabq5358, 2022
822022
HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens
W Fischer, EE Giorgi, S Chakraborty, K Nguyen, T Bhattacharya, J Theiler, ...
Cell host & microbe 29 (7), 1093-1110, 2021
822021
Deep sequencing reveals minor protease resistance mutations in patients failing a protease inhibitor regimen
R Fisher, GU van Zyl, SAA Travers, SL Kosakovsky Pond, S Engelbrech, ...
Journal of virology 86 (11), 6231-6237, 2012
77*2012
Pooling strategies to reduce the cost of HIV-1 RNA load monitoring in a resource-limited setting
GU Van Zyl, W Preiser, S Potschka, AT Lundershausen, R Haubrich, ...
Clinical Infectious Diseases 52 (2), 264-270, 2011
772011
Early Antiretroviral Therapy in South African Children Reduces HIV-1–Infected Cells and Cell-Associated HIV-1 RNA in Blood Mononuclear Cells
GU van Zyl, MA Bedison, AJ van Rensburg, B Laughton, MF Cotton, ...
The Journal of infectious diseases 212 (1), 39-43, 2015
752015
Future technologies for monitoring HIV drug resistance and cure
UM Parikh, K McCormick, G van Zyl, JW Mellors
Current Opinion in HIV and AIDS 12 (2), 182-189, 2017
732017
The system can't perform the operation now. Try again later.
Articles 1–20